In December, a consortium of 8 public and 4 private Swiss institutions has joined forces to address the silent pandemic of AMR by launching…
Pharma company Roche is among the partners of AMR-focused incubator INCATE. We spoke with Rusudan Okujava about the motivation of Roche to support the…
With US$361 million awarded to 92 projects funding, CARB-X closed the fifth fiscal year since inception. In 2021, CARB-X invested in 25 new projects…
In late December, FIND announced an investment of US$21 million to accelerate the development, manufacturing, and launch of affordable, multi-pathogen, molecular diagnostic platforms, specifically…
bye bye
Diagnostics company Ares Genetics GmbH, developing NGS- and AI-powered solutions to combat AMR, has successfully completed Phase 1 of its collaboration with a leading…
The G7 Finance Ministers have released a statement on actions to support antibiotic development, with the goal to strengthen G7 preparedness against the silent pandemic…
The UN Food and Agriculture Organization BioNTFAO has issued an Action Plan spanning a total of 5 years (2021-2025) dedicated at tackling the problem…